An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

Clicks: 240
ID: 111714
2020
Reference Key
schlaich2020expertan Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lakshini Y Herat,Vance B Matthews,Aaron L Magno,Marcio G Kiuchi,Revathy Carnagarin,Markus Schlaich;Lakshini Y Herat;Vance B Matthews;Aaron L Magno;Marcio G Kiuchi;Revathy Carnagarin;Markus Schlaich;
Journal expert opinion on pharmacotherapy
Year 2020
DOI 10.1080/14656566.2020.1751815
URL
https://sciprofiles.com/publication/view/af977d36d6bdebe7d9b36ed786b95eef
Keywords
hypertension Diabetes cardiovascular disease empagliflozin sglt2 sglt2 inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.